Back to results
US 2018/0185462 A1Published application
Peptides for inducing chagas disease responses
AssigneesSaint Louis University, EpiVax, Inc.
InventorsDaniel HOFT, Chris EICKHOFF, Annie DE GROOT
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to vaccine formulations and their use in treating and preventing Chagas Disease.
Claims22
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1-5 and 7-30, or a peptide composition comprising at least two peptides comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1-5 and 7-30.
A method of inducing an immune response in a subject comprising administering to a subject one or more peptides comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1-5 and 7-30.
A vaccine formulation comprising one or more peptides comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1-5 and 7-30.
22-30. (canceled)
Dependencies are inferred from the claim text.